UNICYCIVE THERAPEUTICS, INC. Payments for Repurchase of Warrants
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- UNICYCIVE THERAPEUTICS, INC. payments for repurchase of warrants for the quarter ending 2022-03-31 was $4.78B.
- UNICYCIVE THERAPEUTICS, INC. payments for repurchase of warrants for the quarter ending 2021-12-31 was $0.00.
- UNICYCIVE THERAPEUTICS, INC. payments for repurchase of warrants for the quarter ending 2021-09-30 was $4.78B.
- UNICYCIVE THERAPEUTICS, INC. payments for repurchase of warrants for fiscal 2021 was $4.78B.
| Period end | Payments for Repurchase of Warrants 3 month | Payments for Repurchase of Warrants 12 month |
|---|---|---|
| 2022-03-31 | $4.78B 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $4.78B 10-K · filed 2022-03-31 |
| 2021-09-30 | $4.78B 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |